We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View
Read MoreHide Full Article
Key Takeaways
IDEX beat second-quarter earnings and sales estimates, with organic sales rising 5% year over year.
IEX posted record orders above $1 billion, supported by AI data centers, semiconductors, space and defense.
IDEX raised 2026 organic sales and adjusted earnings guidance after strong second-quarter results.
IDEX Corporation (IEX - Free Report) delivered second-quarter 2026 adjusted earnings of $2.32 per share, topping the Zacks Consensus Estimate of $2.10. The metric rose 12.1% year over year. Net sales of $920.6 million beat the consensus mark of $902.43 million by 2% and increased 6.4% from the year-ago quarter. Organic sales increased 5% year over year. Acquisitions had a positive impact of 1% on sales, while foreign currency translation had no impact.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders of more than $1 billion, signaling improving demand.
Segmental Details
Net sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 2% year over year. The Zacks Consensus Estimate was pegged at $314 million. Organic sales increased 1% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $415 million, up 14% year over year. The consensus estimate was pegged at $407 million. Organic sales increased 12% year over year. Acquisitions/divestitures had a positive impact of 2% on sales, while foreign currency translation had no impact.
Net sales from the Fire & Safety/Diversified Products segment totaled $189.9 million, which decreased 1% year over year. The Zacks Consensus Estimate was pegged at $189 million. Organic sales decreased 1% on a year-over-year basis, while acquisitions/divestitures and foreign currency translation had no impact on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX’s cost of sales increased 4.4% year over year to $493.8 million. The adjusted gross margin was 46.4%, up 110 basis points year over year, reflecting net productivity improvements, volume leverage and positive price-cost dynamics, partially offset by unfavorable mix. Selling, general and administrative expenses increased 10.1% year over year to $224.1 million.
Adjusted EBITDA rose 8.9% to $258.3 million and the adjusted EBITDA margin improved 70 basis points to 28.1%. Operating income increased 6.4% to $199.9 million, aided by improved operating performance. The operating margin was 21.7%, unchanged year over year on a rounded basis. Interest expenses (net) decreased to $15.1 million from $15.6 million in the prior-year period.
Balance Sheet and Cash Flow of IDEX
While exiting the second quarter, IDEX’s cash and cash equivalents were $621.3 million compared with $580 million at the end of 2025. Long-term borrowings (net) were $1.86 billion compared with $1.82 billion at the end of 2025.
In the first six months of 2026, IDEX generated net cash of $303.7 million from operating activities, up 13.6% from the year-ago period. Capital expenditures were $40.7 million compared with $29.1 million in the prior-year period. In the same period, free cash flow was $263 million, up 10.4% year over year.
IDEX paid out dividends totaling $106.7 million in the first six months of 2026, up 0.8% year over year.
IDEX’s Raised 2026 Outlook Reflects Confidence
The company raised its full-year 2026 guidance, projecting organic sales growth of 5-6% compared with prior expectations of 3-4%. The company also lifted its full-year adjusted earnings outlook to $8.70-$8.85 per share from $8.35-$8.55 previously.
For the third quarter of 2026, IDEX expects organic sales to increase 5-7% from the year-ago period and adjusted earnings in the range of $2.20-$2.25 per share.
IEX’s Zacks Rank
The company currently carries a Zacks Rank #3 (Hold).
Constellium SE (CSTM - Free Report) came out with quarterly earnings of $1.04 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $0.91 per share. This compares with earnings of $0.25 per share a year ago.
Constellium posted revenues of $2.75 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 3.5%. This compares with year-ago revenues of $2.1 billion.
Generac Holdings Inc. (GNRC - Free Report) came out with quarterly earnings of $2.91 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $1.95 per share. This compares with earnings of $1.65 per share a year ago.
Generac Holdings posted revenues of $1.17 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.37%. This compares with year-ago revenues of $1.06 billion.
Graco Inc. (GGG - Free Report) reported second-quarter 2026 adjusted earnings of 91 cents per share, up 17% from 78 cents in the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate of 81 cents by 12.4%.
The company’s net sales rose 3% year over year to $590.6 million but lagged the consensus estimate of $609 million by 3%. Organic order backlog (excluding acquisitions) rose 28% from the end of 2025.
View the Zacks #1 Rank List
Image: Bigstock
IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View
Key Takeaways
IDEX Corporation (IEX - Free Report) delivered second-quarter 2026 adjusted earnings of $2.32 per share, topping the Zacks Consensus Estimate of $2.10. The metric rose 12.1% year over year. Net sales of $920.6 million beat the consensus mark of $902.43 million by 2% and increased 6.4% from the year-ago quarter. Organic sales increased 5% year over year. Acquisitions had a positive impact of 1% on sales, while foreign currency translation had no impact.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders of more than $1 billion, signaling improving demand.
Segmental Details
Net sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 2% year over year. The Zacks Consensus Estimate was pegged at $314 million. Organic sales increased 1% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $415 million, up 14% year over year. The consensus estimate was pegged at $407 million. Organic sales increased 12% year over year. Acquisitions/divestitures had a positive impact of 2% on sales, while foreign currency translation had no impact.
Net sales from the Fire & Safety/Diversified Products segment totaled $189.9 million, which decreased 1% year over year. The Zacks Consensus Estimate was pegged at $189 million. Organic sales decreased 1% on a year-over-year basis, while acquisitions/divestitures and foreign currency translation had no impact on sales.
IDEX Corporation Price, Consensus and EPS Surprise
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
IDEX’s Margin Profile
IDEX’s cost of sales increased 4.4% year over year to $493.8 million. The adjusted gross margin was 46.4%, up 110 basis points year over year, reflecting net productivity improvements, volume leverage and positive price-cost dynamics, partially offset by unfavorable mix. Selling, general and administrative expenses increased 10.1% year over year to $224.1 million.
Adjusted EBITDA rose 8.9% to $258.3 million and the adjusted EBITDA margin improved 70 basis points to 28.1%. Operating income increased 6.4% to $199.9 million, aided by improved operating performance. The operating margin was 21.7%, unchanged year over year on a rounded basis. Interest expenses (net) decreased to $15.1 million from $15.6 million in the prior-year period.
Balance Sheet and Cash Flow of IDEX
While exiting the second quarter, IDEX’s cash and cash equivalents were $621.3 million compared with $580 million at the end of 2025. Long-term borrowings (net) were $1.86 billion compared with $1.82 billion at the end of 2025.
In the first six months of 2026, IDEX generated net cash of $303.7 million from operating activities, up 13.6% from the year-ago period. Capital expenditures were $40.7 million compared with $29.1 million in the prior-year period. In the same period, free cash flow was $263 million, up 10.4% year over year.
IDEX paid out dividends totaling $106.7 million in the first six months of 2026, up 0.8% year over year.
IDEX’s Raised 2026 Outlook Reflects Confidence
The company raised its full-year 2026 guidance, projecting organic sales growth of 5-6% compared with prior expectations of 3-4%. The company also lifted its full-year adjusted earnings outlook to $8.70-$8.85 per share from $8.35-$8.55 previously.
For the third quarter of 2026, IDEX expects organic sales to increase 5-7% from the year-ago period and adjusted earnings in the range of $2.20-$2.25 per share.
IEX’s Zacks Rank
The company currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Companies
Constellium SE (CSTM - Free Report) came out with quarterly earnings of $1.04 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $0.91 per share. This compares with earnings of $0.25 per share a year ago.
Constellium posted revenues of $2.75 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 3.5%. This compares with year-ago revenues of $2.1 billion.
Generac Holdings Inc. (GNRC - Free Report) came out with quarterly earnings of $2.91 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $1.95 per share. This compares with earnings of $1.65 per share a year ago.
Generac Holdings posted revenues of $1.17 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.37%. This compares with year-ago revenues of $1.06 billion.
Graco Inc. (GGG - Free Report) reported second-quarter 2026 adjusted earnings of 91 cents per share, up 17% from 78 cents in the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate of 81 cents by 12.4%.
The company’s net sales rose 3% year over year to $590.6 million but lagged the consensus estimate of $609 million by 3%. Organic order backlog (excluding acquisitions) rose 28% from the end of 2025.